BridgeBio Oncology Therapeutics, Inc. (BBOT)

BBOT Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	52.66	373.69	30.85	-	-
Short-Term Investments	199.62	51.77	124.78	-	-
Cash & Short-Term Investments	252.28	425.46	155.63	-	-
Cash Growth	26093.11%	173.38%	-	-	-
Accounts Receivable	0.15	0.39	0.08	-	-
Other Current Assets	14.08	6.55	2.98	-	-
Total Current Assets	266.5	432.4	158.69	-	-
Net Property, Plant & Equipment	3.16	3.29	0.49	-	-
Long-Term Investments	136.62	-	-	-	-
Other Long-Term Assets	11.37	12.7	5.12	0.33	0.14
Total Assets	417.65	448.38	164.3	0.33	0.14
Accounts Payable	12.09	1.37	3.07	0.02	-
Accrued Expenses	29.37	32.37	12.75	-	-
Current Portion of Leases	0.54	0.52	-	-	-
Other Current Liabilities	1.26	0.77	3.75	0.38	0.17
Total Current Liabilities	43.26	35.04	19.58	0.4	0.17
Long-Term Leases	2.11	2.24	-	-	-
Total Long-Term Liabilities	2.11	2.24	-	-	-
Total Liabilities	45.37	37.29	19.58	0.4	0.17
Common Stock	0.01	0.01	-	0	0
Additional Paid-in Capital	771.93	767.64	43.54	0.02	0.02
Accumulated Other Comprehensive Income	-0.98	0.02	0.35	-	-
Retained Earnings	-398.67	-356.57	-222.52	-0.09	-0.05
Minority Interest	-	-	323.36	-	-
Shareholders' Equity	372.28	411.1	-178.64	-0.06	-0.02
Total Liabilities & Equity	417.65	448.38	164.3	0.33	0.14
Total Debt	2.64	2.77	0	0	0
Net Cash (Debt)	249.63	422.69	155.63	-0	-0
Net Cash Growth	-40.94%	171.60%	-	-	-
Net Cash Per Share	15.96	13.57	5.00	-	-
Book Value	372.28	411.1	-178.64	-0.06	-0.02
Book Value Per Share	23.80	13.20	-5.74	-0.02	-0.01
Tangible Book Value	372.28	411.1	-178.64	-0.06	-0.02
Tangible Book Value Per Share	23.80	13.20	-5.74	-0.02	-0.01

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.